Financials
Financial year 2025
Klinische Biologie ZOL from Heusden-Zolder, company number BE0797347027, closed financial year 2025 with a result of € 0 after tax. For that financial year Klinische Biologie ZOL recorded a gross margin of € 3,676 and equity of € 4,500. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 4,500
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 21,991
▼ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 538
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 1,472 | € 2,914 | € 3,676 | ▲ 26% |
| Equity | € 4,500 | € 4,500 | € 4,500 | |
| Total debts | € 2,294,595 | € 2,365,402 | € 2,512,491 | ▲ 6% |
| Cash | € 26,595 | € 30,492 | € 21,991 | ▼ 28% |
| Balance sheet total | € 2,299,095 | € 2,369,902 | € 2,516,991 | ▲ 6% |
Key figures of Klinische Biologie ZOL, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Klinische Biologie ZOL?
What happened at Klinische Biologie ZOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- New establishment in Heusden-Zolder. KBO
- Dr. Oris Els BV became a director. NBB
- Niels Graindor BV became a director. NBB
- Dr. K. Van Pelt BV became a director. NBB
- Dr. Joris Penders BV became a director. NBB
- Stockmans-Resseler BV became a director. NBB
- DEB.S BV became a director. NBB
In short
From € 0 profit in 2023 to € 0 profit in 2025.
Paid € 3,474 in corporate taxes since 2023.
A new publication or filing at Klinische Biologie ZOL? We notify you, reason included.
Follow Klinische Biologie ZOLDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NIELS GRAINDOR, DANSAERT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Klinische Biologie ZOLBehind Klinische Biologie ZOL are Dr. Oris Els BV, Niels Graindor BV, Dr. K. Van Pelt BV, Dr. Joris Penders BV, Stockmans-Resseler BV and DEB.S BV. The shares are held by NIELS GRAINDOR (11.1%) and DANSAERT (11%).
Directors
According to the 2025 annual accounts
Director · represented by Els Oris
since 2023
Director · represented by Niels Graindor
since 2023
Director · represented by Kristien Van Pelt
since 2023
Director · represented by Joris Penders
since 2023
Director · represented by Sarah Resseler
since 2023
Director · represented by Deborah Steensels
since 2023
Director · represented by Ben Persy
since 2023
Director · represented by Toon Schiemsky
since 2023
Shareholders
11.1%
11%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Heidestraat 86
3550 Heusden-Zolder
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0797.347.027
- VAT number
- BE 0797.347.027
- Registered office
- Heidestraat 86, 3550 Heusden-Zolder
- Names & denominations
- Klinische Biologie ZOL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 2023
- Peppol
- Active · Active since 1 Oct 2024
- Activities · NACE
Activiteiten van medisch specialisten